Update on gastroesophageal reflux disease

Gastroenterología y hepatología
Jordi Serra Pueyo

Abstract

Gastroesophageal reflux disease is a highly frequent disorder classically characterized by the presence of heartburn and/or acid regurgitation that improves with drug therapy that reduces acid content in the stomach. However, especially in patients with non-erosive disease, response to proton pump inhibitors is unsatisfactory in approximately 1 out of 3 patients, and consequently, in these patients, it is important to establish a definitive diagnosis and an alternative therapeutic strategy. In the last few years, advances have been made in knowledge of the physiopathology of reflux, such as identification of the role of the acid pocket in producing reflux, technological advances that allow differentiation among acid reflux, non-acid reflux and slightly acid reflux, and advances in the treatment of reflux with drugs that attempt to act on the barrier function of the esophagogastric junction.

References

Dec 16, 1982·The New England Journal of Medicine·W J DoddsM S Egide
Nov 15, 1997·Scandinavian Journal of Gastroenterology·T LindA Stubberöd
May 23, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·John E PandolfinoPeter J Kahrilas
Dec 23, 2003·Alimentary Pharmacology & Therapeutics·M Diaz-RubioF Rodriguez-Artalejo
Aug 4, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Bonnie B DeanRonnie Fass
Aug 19, 2004·European Journal of Gastroenterology & Hepatology·Daniel Sifrim
May 26, 2005·Current Gastroenterology Reports·Sara Emerenziani, Daniel Sifrim
Aug 27, 2005·Gut·A J BredenoordA J P M Smout
Jan 6, 2006·Alimentary Pharmacology & Therapeutics·J PonceUNKNOWN Iberge Study Group
May 10, 2006·Archives of Internal Medicine·Tonya KaltenbachLauren B Gerson
Jan 19, 2007·Alimentary Pharmacology & Therapeutics·T TranH B El-Serag
Jun 27, 2007·Alimentary Pharmacology & Therapeutics·G E E Boeckxstaens
Mar 25, 2010·Gut·Kenneth E L McCollJohn Seenan
May 25, 2010·The American Journal of Medicine·Brian E LacyMichael F Vaezi
Jul 14, 2010·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·F AzpirozM J Soria
Nov 5, 2011·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·N ManabeS Tanaka
Nov 15, 2011·Alimentary Pharmacology & Therapeutics·T HershcoviciR Fass
Jan 14, 2012·Alimentary Pharmacology & Therapeutics·T M T Nguyen, G D Eslick
Jan 26, 2012·Endoscopy·S RomanS Bruley des Varannes
Mar 13, 2013·Lancet·Albert J BredenoordAndré J P M Smout
May 15, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Wout O RohofGuy E Boeckxstaens
Sep 4, 2013·Best Practice & Research. Clinical Gastroenterology·Peter J KahrilasAndre J P M Smout
Feb 1, 2013·United European Gastroenterology Journal·Frank ZerbibLars Lundell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Edoardo SavarinoV Savarino
European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Andrés Coca-PelazAlfio Ferlito
© 2021 Meta ULC. All rights reserved